Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma
Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2021-06-01. On CanQuery you can follow the original downloads. Files are available in English and French.
This guidance document provides sponsors of subsequent entry inhaled corticosteroid (ICS) products for the treatment of asthma with information on the comparative clinical data requirements in order to establish the safety and effectiveness of their products under Section C.08 of the Food and Drug Regulations.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-06-01
Data overview
- Formats
- HTML
- File languages
- English, French
Official sources and licences
Resources
- Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma (French, HTML) HTML · Download HTML
- Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma (English, HTML) HTML · Download HTML